Figure 1.
Commonly used myeloablative and reduced intensity conditioning regimens in acute lymphoblastic leukemia in the US, 2019–2022.67 MAC, myeloablative conditioning; RIC/NMA, reduced intensity conditioning/non-myeloablative regimen; Bu, busulfan; Cy, cyclophosphamide; Flu, fludarabine; Mel, melphalan; TBI, total body irradiation.